BioPharm International eBulletin
Having trouble viewing this e-mail? CLICK HERE

advertisement
BioPharm International
Notice to our subscribers currently receiving printed copies of our magazine: Due to COVID-19, we are delivering each issue to you via email. Please note your issues will also still be delivered to you via postal mail, and will be awaiting your return to the office. If you wish to change your delivery address, or delivery preference, you can do so via our online subscription form.
 
April 21, 2020
WEBSITE CURRENT ISSUE SUBSCRIBE FORWARD

TOP STORIES


COVID-19 Update

Updates on COVID-19 vaccine candidates, FDA policies, company partnerships, and more.
/ read more /

Alnylam Pharmaceuticals and Blackstone Life Sciences Enter into Collaboration for up to $2 Billion

The companies announced they are entering into a strategic collaboration under which Blackstone will provide up to $2 billion to fund Alnylam’s RNAi drugs to treat a range of diseases.
/ read more /

 
ADVERTISEMENT

Featured Resources from BioPharm International
View our online resource center, sponsored by GE Healthcare, to explore a case study and articles on gaining and retaining skilled labor, modular bioprocessing, the good and bad of biosilimiars, and more.
Learn More »

Subscribe

Subscribers can enjoy each full issue of BioPharm International in print, or via BioPharm apps.

subscription offers
subscribe
 
advertisement

Industry News


Maintaining GMPs During a Global Emergency

Experts to discuss strategies for ensuring supply of quality drug products during a pandemic in April 28 online event.
/ read more /


Expert Working Group Finds Insufficient Evidence Linking Ibuprofen and COVID-19 Susceptibility

The Commission of Human Medicines Expert Working Group has concluded that there is insufficient evidence to link ibuprofen, or other non-steroidal anti-inflammatory drugs (NSAIDs), with susceptibility for contracting COVID-19 or worsening symptoms.
/ read more /


MORE INDUSTRY NEWS
advertisement
 

Biopharma News


TScan Therapeutics, Novartis Collaborate on T-Cell Receptor Therapies

Biopharmaceutical company, TScan Therapeutics, has entered into a collaboration agreement with Novartis that is aimed at the discovery and development of novel T-cell receptor (TCR) therapies for solid tumors.
/ read more /


Sanofi, GSK Collaborate on Adjuvanted Vaccine for COVID-19

Sanofi and GlaxoSmithKline (GSK) have revealed that they are joining forces to develop an adjuvanted vaccine using their respective technologies that can be used to fight COVID-19.
/ read more /


More Biopharma News
 

Supplier News


Supplier Operations Status Report

Suppliers to the bio/pharma industry are sharing news about the business operations during the global COVID-19 pandemic. To view current information about the company’s business operations, click the company name.
/ read more /



HALIX Joins Consortium of Partners to Provide GMP Services for COVID-19 Vaccine

Dutch company HALIX has announced it is joining a consortium of partners that are all under the guidance of the University of Oxford to provide good manufacturing practice (GMP) manufacturing services for a COVID-19 vaccine.
/ read more /


More Supplier News

Regulatory News


FDA Continues to Warn Companies Marketing Products to Treat COVID-19

The agency sent warning letters to three more companies for selling unapproved products claiming to treat COVID-19.
/ read more /



EMA Publishes COVID-19 Q&A Guidance

The guidance answers questions on changes made to the regulatory framework to address challenges during the COVID-19 pandemic.
/ read more /


More Regulatory News

FEATURED TOPICS

OUTSOURCING

Ensuring Smooth Tech Transfer of Bioprocess Operations

Experience, communication, collaboration, transparency, planning, and prioritization contribute to success.
/ read more /

 

FORMULATION

On Point: Biologics Drive Growth in Pre-Filled Syringes

As a result of the rising use and development of biological drugs, the biopharma industry is witnessing an increase in the adoption of prefilled syringes.
/ read more /


DOWNSTREAM PROCESSING

What’s New in Downstream Technologies

The latest advances in downstream technologies include a fluid chromatography system, sensing and control units for hygienic valves, a compact valve platform, a membrane purification column, and a protein A affinity chromatography resin.
/ read more /

REGULATORY BEAT

Biosimilars Poised for Gains in US Market

FDA is encouraging alternative insulins and challenging anticompetitive practices.
/ read more /


WEBCASTS


Simple and Effective Methods for Purification and Determination of Molecular Weight of DMT-on and DMT-off Oligonucleotides
Wednesday, April 22, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Learn More


Implementing Attribute Monitoring Analyses for Biopharmaceutical Development and QC
Wednesday, April 29, 2020, 9am EDT| 2pm BST| 3pm CEST
Learn More


Practical Method Development Strategies for the Analysis of Monoclonal Antibodies by Reversed-Phase HPLC
Thursday, May 21, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Learn More


An In-Depth Look at Intact Biotherapeutic Characterization and Quantitation in Biological Matrices
Europe Broadcast: Thursday, April 23, 2020 at 9am EDT | 2pm BST | 3pm CEST
US Broadcast: Thursday, April 23, 2020 at 2pm EDT | 1pm CDT | 11am PDT
Learn More


Ensuring the Continuous Supply of Quality Drug Products During Uncertain Times
Tuesday, April 28, 2020, 11 am EDT | 10 am CDT | 8 am PDT
Learn More



Rescheduled Events

CPhI South East Asia

CPhI South East Asia has been rescheduled for July 2020.

Interphex 2020

Interphex 2020 has been rescheduled for July 2020.

69th PDA Annual Meeting

PDA’s Annual Meeting has been rescheduled for July 2020.

Bioprocessing Summit Europe

Bioprocessing Summit Europe has been rescheduled for July 2020.

PDA Pharmaceutical Manufacturing Data Science Workshop

PDA’s Pharmaceutical Manufacturing Data Science Workshop has been rescheduled for July 2020.

CPhI North America

CPhI North America has been rescheduled for September 2020.

CPhI Japan

CPhI Japan has been rescheduled for September 2020.

Analytica 2020

Analytica 2020 has been rescheduled for October 2020.

Interpack 2020

Interpack 2020 has been rescheduled for February 2021.

more events

eBook

Regulatory Sourcebook and Reference, March 2020

The Pharmacopoeia Compliance Series features a description of ways biopharma companies can participate in monograph development, a case study of a practical approach to pharmacopoeial compliance, and a summary of this 12-part series.

contribute | CONTACT EDITORS | CONTACT SALES | subscribe | advertise